Overview

Evaluation of Pain and Inflammation After Injection of Lucentis vs Eylea for Treatment of Wet Macular Degeneration

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
This study is designed to compare the post injection inflammation and pain seen after intravitreal injections of Ranibizumab vs Aflibercept.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Arshad Khanani
Collaborator:
Genentech, Inc.
Treatments:
Aflibercept
Ranibizumab